Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Constantina A. Pappa
Observed names:
C A Pappa,
C Pappa,
C. A. Pappa,
C. PAPPA,
C. Pappa,
C.A. Pappa,
Constantina A Pappa,
Constantina Pappa
show all 8
Institution:
The General Hospital of Heraklion "Venizeleio-Pananio"
Observed institutions:
University of Crete,
University of Thessaly,
National and Kapodistrian University of Athens,
University Hospital of Larissa,
The General Hospital of Heraklion "Venizeleio-Pananio",
University Hospital of Heraklion
show all 6
OpenAlex ID:
A5111701311
Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer-Related Thrombocytosis
2003
·
Michael G. Alexandrakis
, Freda H. Passam
, et al.
·
American Journal of Clinical Oncology
·
198
Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma
2006
·
Michael G. Alexandrakis
, Constantina A. Pappa
, et al.
·
European Journal of Internal Medicine
·
70
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
2015
·
Michael G. Alexandrakis
, Nektaria Goulidaki
, et al.
·
Pathology & Oncology Research
·
58
The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma
2004
·
M G Alexandrakis
, F H Passam
, et al.
·
Journal of Clinical Pathology
·
46
PDF
Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival
2003
·
M.G Alexandrakis
, F.H Passam
, et al.
·
Leukemia Research
·
45
Role of platelet‐derived growth factor‐AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma
2011
·
George Tsirakis
, Constantina A. Pappa
, et al.
·
Hematological Oncology
·
38
Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma
2007
·
C. Pappa
, S. Miyakis
, et al.
·
Cytokine
·
36
Serum Evaluation of Angiogenic Cytokines Basic Fibroblast Growth Factor, Hepatocyte Growth Factor and TNF-ALPHA in Patients with Myelodysplastic Syndromes: Correlation with Bone Marrow Microvascular Density
2005
·
M.G. Alexandrakis
, F.H. Passam
, et al.
·
International Journal of Immunopathology and Pharmacology
·
36
PDF
Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes
2004
·
Michael G. Alexandrakis
, Freda H. Passam
, et al.
·
Leukemia Research
·
35
Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma
2012
·
M. Fragioudaki
, G. Tsirakis
, et al.
·
Leukemia Research
·
34
Serum Levels of Leptin in Multiple Myeloma Patients and Its Relation to Angiogenic and Inflammatory Cytokines
2004
·
M.G. Alexandrakis
, F.H. Passam
, et al.
·
The International Journal of Biological Markers
·
32
B cell-activating factor: its clinical significance in multiple myeloma patients
2012
·
M. Fragioudaki
, A. Boula
, et al.
·
Annals of Hematology
·
29
Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma
2011
·
Aikaterini Sfiridaki
, Spiros Miyakis
, et al.
·
Journal of Hematology & Oncology
·
28
PDF
Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma
2006
·
Michael G. Alexandrakis
, Aikaterini Sfiridaki
, et al.
·
Clinica Chimica Acta
·
26
The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients
2015
·
Rodanthi Vyzoukaki
, George Tsirakis
, et al.
·
International Archives of Allergy and Immunology
·
24
Relationship between Circulating BAFF Serum Levels with Proliferating Markers in Patients with Multiple Myeloma
2013
·
Michael G. Alexandrakis
, Parascevi Roussou
, et al.
·
BioMed Research International
·
24
PDF
Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma
2011
·
C.A. Pappa
, G. Tsirakis
, et al.
·
Cytokine
·
24
Angiogenesis‐related growth factors and cytokines in the serum of patients with B non‐Hodgkin lymphoma; relation to clinical features and response to treatment
2007
·
F. H. PASSAM
, A. SFIRIDAKI
, et al.
·
International Journal of Laboratory Hematology
·
24
Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients
2011
·
G. Tsirakis
, C. A. Pappa
, et al.
·
European Journal of Histochemistry
·
23
PDF
Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment
2011
·
K. Sfiridaki
, C. A. Pappa
, et al.
·
Mediators of Inflammation
·
20
PDF
Expression of Proliferating Cell Nuclear Antigen (PCNA) in Multiple Myeloma: Its Relationship to Bone Marrow Microvessel Density and other Factors of Disease Activity
2004
·
M.G. Alexandrakis
, F.H. Passam
, et al.
·
International Journal of Immunopathology and Pharmacology
·
18
Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma
2012
·
G. Tsirakis
, C.A. Pappa
, et al.
·
European Journal of Internal Medicine
·
17
Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma
2013
·
Constantina A Pappa
, George Tsirakis
, et al.
·
Cancer Investigation
·
15
Prognostic impact of angiopoietin-2 in multiple myeloma
2014
·
Constantina A. Pappa
, Michael G. Alexandrakis
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
14
Increased serum levels of MIP-1alpha correlate with bone disease and angiogenic cytokines in patients with multiple myeloma
2013
·
George Tsirakis
, Parascevi Roussou
, et al.
·
Medical Oncology
·
14
Show more works
View as search
Works count:
40
Citation count:
1,048
H-index:
20
I10-index:
31
Year
Topic
Type
